Alberto Villanueva Selected Research

trans-activation responsive RNA-binding protein

3/2011	Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing.
3/2009	A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alberto Villanueva Research Topics

Disease

81	Neoplasms (Cancer) 04/2022 - 03/2002
13	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 04/2006
10	Neoplasm Metastasis (Metastasis) 10/2020 - 06/2007
8	Breast Neoplasms (Breast Cancer) 11/2019 - 09/2009
7	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 10/2012
6	Carcinoma (Carcinomatosis) 01/2021 - 03/2009
5	Lung Neoplasms (Lung Cancer) 01/2021 - 12/2007
5	Carcinogenesis 01/2019 - 04/2009
5	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2018 - 05/2009
4	Neurofibrosarcoma (MPNST) 01/2022 - 01/2013
3	Adenocarcinoma of Lung 01/2020 - 01/2016
3	Ovarian Epithelial Carcinoma 01/2018 - 10/2012
3	Pulmonary Embolism 03/2013 - 05/2009
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2021 - 09/2015
2	Melanoma (Melanoma, Malignant) 01/2021 - 07/2015
2	Colonic Neoplasms (Colon Cancer) 01/2020 - 01/2018
2	Glioblastoma (Glioblastoma Multiforme) 09/2017 - 09/2012
2	Hepatocellular Carcinoma (Hepatoma) 03/2017 - 02/2016
2	Sarcoma (Soft Tissue Sarcoma) 03/2016 - 01/2016
2	Choriocarcinoma 08/2013 - 05/2009
2	Microsatellite Instability 10/2010 - 03/2009
1	Rhabdomyosarcoma 04/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Cholangiocarcinoma 12/2021
1	Fibrosis (Cirrhosis) 12/2021
1	Cysts 12/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2021
1	Malignant Mesothelioma 11/2021
1	Neuroblastoma 10/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Hodgkin Disease (Hodgkin's Disease) 01/2021
1	Small Cell Carcinoma 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Uveal melanoma 10/2020

Drug/Important Bio-Agent (IBA)

11	Pharmaceutical PreparationsIBA 01/2022 - 09/2008
10	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 05/2009
9	MicroRNAs (MicroRNA)IBA 01/2019 - 09/2008
8	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2012
7	Biomarkers (Surrogate Marker)IBA 09/2021 - 11/2012
7	EnzymesIBA 04/2021 - 02/2016
7	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2002
6	RNA (Ribonucleic Acid)IBA 04/2021 - 03/2017
6	Messenger RNA (mRNA)IBA 11/2019 - 03/2002
4	PlatinumIBA 11/2021 - 10/2012
4	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 05/2015
4	Phosphotransferases (Kinase)IBA 01/2020 - 10/2012
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2022 - 07/2015
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 05/2015
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2021 - 09/2016
3	Conditioned Culture MediaIBA 05/2021 - 10/2011
3	Therapeutic UsesIBA 01/2020 - 01/2017
3	Biological ProductsIBA 01/2020 - 11/2009
3	Protein Isoforms (Isoforms)IBA 11/2019 - 10/2012
3	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 04/2006
2	trametinibIBA 04/2022 - 01/2020
2	S63845IBA 04/2022 - 01/2020
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2022 - 05/2014
2	carfilzomibIBA 01/2022 - 01/2021
2	Transfer RNA (tRNA)IBA 04/2021 - 01/2020
2	Adenosine Triphosphate (ATP)IBA 01/2020 - 02/2016
2	MethyltransferasesIBA 12/2019 - 06/2018
2	ProteomeIBA 12/2019 - 04/2014
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018 - 05/2009
2	LigandsIBA 01/2018 - 04/2009
2	Small Interfering RNA (siRNA)IBA 01/2018 - 04/2016
2	SurvivinIBA 09/2016 - 01/2014
2	Drug CombinationsIBA 01/2016 - 01/2016
2	A-Form DNA (A-DNA)IBA 10/2012 - 09/2008
2	trans-activation responsive RNA-binding proteinIBA 03/2011 - 03/2009
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2022
1	adavosertibIBA 01/2022
1	Bispecific AntibodiesIBA 01/2022
1	PanobinostatIBA 01/2022
1	torinIBA 01/2022
1	8- (6- methoxypyridin- 3- yl)- 3- methyl- 1- (4- piperazin- 1- yl- 3- trifluoromethylphenyl)- 1,3- dihydroimidazo(4,5- c)quinolin- 2- oneIBA 01/2022
1	Thioacetamide (Thioacetamid)IBA 12/2021
1	Mitogen-Activated Protein Kinase 8IBA 12/2021
1	TunicamycinIBA 12/2021
1	Arsenic Trioxide (Trisenox)FDA Link 04/2021
1	Selenoproteins (Selenoprotein)IBA 04/2021
1	daratumumabIBA 01/2021
1	GSK-J4IBA 01/2021
1	Lenalidomide (CC 5013)FDA Link 01/2021
1	Gefitinib (Iressa)FDA Link 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	CollagenIBA 01/2021
1	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 10/2020
1	AS 8IBA 10/2020
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2020
1	Gemcitabine FDA Link 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	RNA Polymerase I (Polymerase I, RNA)IBA 01/2020
1	Calcibiotic Root Canal SealerIBA 01/2020

Therapy/Procedure

25	Therapeutics 02/2022 - 08/2004
19	Drug Therapy (Chemotherapy) 01/2022 - 06/2007
4	Radiotherapy 01/2021 - 09/2009
3	Precision Medicine 01/2022 - 05/2015
3	Catheters 03/2013 - 05/2009
2	Immunotherapy 11/2021 - 09/2021
1	Aftercare (After-Treatment) 01/2021